These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 17872334)

  • 41. MicroRNA dysregulation in esophageal neoplasia: the biological rationale for novel therapeutic options.
    Fassan M; Baffa R; Kiss A; Zaninotto G; Rugge M
    Curr Pharm Des; 2013; 19(7):1236-41. PubMed ID: 23092347
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Gene therapy for cancer.
    Gunji Y; Ochiai T; Shimada H; Matsubara H
    Surg Today; 2000; 30(11):967-73. PubMed ID: 11110389
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Esophageal Cancer Genetics and Clinical Translation.
    Jajosky A; Fels Elliott DR
    Thorac Surg Clin; 2022 Nov; 32(4):425-435. PubMed ID: 36266030
    [TBL] [Abstract][Full Text] [Related]  

  • 44. International cancer seminars: a focus on esophageal squamous cell carcinoma.
    Murphy G; McCormack V; Abedi-Ardekani B; Arnold M; Camargo MC; Dar NA; Dawsey SM; Etemadi A; Fitzgerald RC; Fleischer DE; Freedman ND; Goldstein AM; Gopal S; Hashemian M; Hu N; Hyland PL; Kaimila B; Kamangar F; Malekzadeh R; Mathew CG; Menya D; Mulima G; Mwachiro MM; Mwasamwaja A; Pritchett N; Qiao YL; Ribeiro-Pinto LF; Ricciardone M; Schüz J; Sitas F; Taylor PR; Van Loon K; Wang SM; Wei WQ; Wild CP; Wu C; Abnet CC; Chanock SJ; Brennan P
    Ann Oncol; 2017 Sep; 28(9):2086-2093. PubMed ID: 28911061
    [TBL] [Abstract][Full Text] [Related]  

  • 45. MMP7 Polymorphisms - A new tool in molecular pathology to understand esophageal cancer.
    Bavi PP; Bu R; Uddin S; Al-Kuraya KS
    Saudi J Gastroenterol; 2011; 17(5):299-300. PubMed ID: 21912054
    [No Abstract]   [Full Text] [Related]  

  • 46. [Therapy of spinocellular carcinoma of the esophagus].
    Pafko P; Kabát J
    Rozhl Chir; 1994 Feb; 73(1):24-5. PubMed ID: 8160082
    [No Abstract]   [Full Text] [Related]  

  • 47. The multi-disciplinary approach in the management of squamous carcinoma of the oesophagus: the Groote Schuur Hospital experience: September 1971-September 1976.
    Werner ID
    Front Gastrointest Res; 1979; 5():130-5. PubMed ID: 499975
    [No Abstract]   [Full Text] [Related]  

  • 48. C-myc oncogene activation in pharyngeal-esophageal squamous cell carcinoma.
    Tsounis D; Falidas E; Monastirioti AE; Tsiambas E
    J BUON; 2021; 26(4):1686-1687. PubMed ID: 34565041
    [No Abstract]   [Full Text] [Related]  

  • 49. Targeting genetic lesions in esophageal cancer.
    Lin DC; Wang MR; Koeffler HP
    Cell Cycle; 2014; 13(13):2013-4. PubMed ID: 24901941
    [No Abstract]   [Full Text] [Related]  

  • 50. Familial aggregation of esophageal cancer.
    Li S; Hopper JL
    Chin Med J (Engl); 2023 Nov; 136(21):2644-2646. PubMed ID: 37925596
    [No Abstract]   [Full Text] [Related]  

  • 51. Antisense oncogene and tumor suppressor gene therapy of cancer.
    Zhang WW
    J Mol Med (Berl); 1996 Apr; 74(4):191-204. PubMed ID: 8740650
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Molecular cytogenetic analysis of carcinomas of the digestive organs and its clinical application.
    Sasaki K
    Intern Med; 2003 Mar; 42(3):292-4. PubMed ID: 12705801
    [No Abstract]   [Full Text] [Related]  

  • 53. Inhibition of human esophageal squamous cell carcinomas by targeted silencing of tumor enhancer genes: an overview.
    Islamian JP; Mohammadi M; Baradaran B
    Cancer Biol Med; 2014 Jun; 11(2):78-85. PubMed ID: 25009749
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Squamous esophageal cancer--introduction.
    Wong J
    World J Surg; 1994; 18(3):307. PubMed ID: 8091768
    [No Abstract]   [Full Text] [Related]  

  • 55. For esophageal cancer, biology is still king.
    Ng T
    J Thorac Cardiovasc Surg; 2016 Sep; 152(3):761-2. PubMed ID: 27325491
    [No Abstract]   [Full Text] [Related]  

  • 56. Therapeutic implications of molecular genetics.
    Hamilton SR
    Adv Exp Med Biol; 1993; 339():297-301; discussion 303-4. PubMed ID: 8178725
    [No Abstract]   [Full Text] [Related]  

  • 57. Evolving therapies in esophageal carcinoma.
    Hofstetter WL
    Thorac Surg Clin; 2013 Nov; 23(4):ix-x. PubMed ID: 24199707
    [No Abstract]   [Full Text] [Related]  

  • 58. A novel therapeutic approach for esophageal squamous cell carcinoma: suppressor of cytokine signaling-1 gene therapy.
    Chen CH; Li SH
    J Thorac Dis; 2017 Jun; 9(6):1446-1449. PubMed ID: 28740654
    [No Abstract]   [Full Text] [Related]  

  • 59. Mend and Cure with Surgery.
    Koyyala VPB
    Int J Radiat Oncol Biol Phys; 2022 Jul; 113(4):716. PubMed ID: 35772439
    [No Abstract]   [Full Text] [Related]  

  • 60. Identification of galectin-7 as a potential biomarker for esophageal squamous cell carcinoma by proteomic analysis.
    Zhu X; Ding M; Yu ML; Feng MX; Tan LJ; Zhao FK
    BMC Cancer; 2010 Jun; 10():290. PubMed ID: 20546628
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.